UK and Denmark are dropped from the reference country basket for price revisions in Spain
Submitted by THE HEALTH ECONOMICS BLOG
It´s good to see that some countries health authorities finally wake up to the issues caused by the declining British pound and other non Euro currencies on pharmaceutical prices through international reference pricing, at launch or during regular revisions. In a public meeting last week a member of the pricing comission of the Spanish ministry of health stated that the UK and Denmark will from now on be excluded from that process, however the small caveat is that potentially Greek prices will get more attention.
Some more comments can be found at this weeks edition of El Global.
Cheers
Ulf
We don't know every stock and we want to know your thoughts. Register on Biotech Stocks Blog now and get published within minutes. Before posting, it is recommended that you review our posting guidelines.
